---
title: "PDS Biotechnology (PDSB.US) — Financial Reports"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/PDSB.US/norm.md"
symbol: "PDSB.US"
name: "PDS Biotechnology"
parent: "https://longbridge.com/en/quote/PDSB.US.md"
datetime: "2026-05-21T05:56:48.583Z"
locales:
  - [en](https://longbridge.com/en/quote/PDSB.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/PDSB.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/PDSB.US/norm.md)
---

# PDS Biotechnology (PDSB.US) — Financial Reports

## Income Statement (USD)

| Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| EPS | -0.1324 | -0.1466 | -0.1922 | -0.2055 | -0.2095 |
| ROE | -317.73% | -323.45% | -283.61% | -196.95% | -164.17% |
| Revenue | - | - | - | - | - |
| Net income | -7.35M | -7.56M | -9.01M | -9.43M | -8.49M |
| Operating income | -6.52M | -6.67M | -8.14M | -7.62M | -9.11M |
| Gross margin | - | - | - | - | - |
| Net margin | - | - | - | - | - |
| Profit quality | - | - | - | - | - |

## Balance Sheet (USD)

| Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| A&L | - | 30.49M | 34.71M | 40.48M | 47.03M |
| Leverage | - | 3.30 | 3.67 | 2.54 | 2.10 |
| BVPS | - | 0.1686 | 0.1982 | 0.3422 | 0.4921 |
| Turnover | - | - | - | - | - |
| Cash & STI | - | 26.71M | 26.20M | 31.87M | 39.98M |
| Inv & Rec | - | - | - | - | - |
| LT assets | - | 243698.00 | 258827.00 | 273956.00 | 289085.00 |
| Net debt | - | -9.79M | -8.23M | -13.34M | -21.02M |

## Cash Flow Statement (USD)

| Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| Operating CF | - | -3.70M | -5.92M | -9.10M | -9.03M |
| Investing CF | - | - | - | - | - |
| Financing CF | - | 4.22M | 241205.00 | 995944.00 | 7.32M |
| Free CF | - | -6.02M | -2.44M | -3.31M | -2.37M |
| OCF coverage | - | -198.00% | -582.60% | -46.19% | -287.67% |
| Repaid & issued | - | -1.07M | 4.00 | 19.24M | - |
| CapEx | - | - | - | - | - |